Selpercatinib mitigates microglia-mediated neuroinflammation by inhibiting RET signaling and NLRP3 inflammasome activation
- DOI
- 10.3389/fimmu.2026.1899666
- Published
- 2026-09-23
- Container
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1899666,
title = {Selpercatinib mitigates microglia-mediated neuroinflammation by inhibiting RET signaling and NLRP3 inflammasome activation},
author = {Jung Ki Min and Daeun Park and Hanwoong Woo and Sohee Kim and Juyeon Lee and Yeonsu Kim and Jeong-im Choi and Eunbi Lim and Sehyun Chae and Jieun Kim},
year = {2026},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2026.1899666},
url = {https://doi.org/10.3389/fimmu.2026.1899666}
}RIS
TY - JOUR TI - Selpercatinib mitigates microglia-mediated neuroinflammation by inhibiting RET signaling and NLRP3 inflammasome activation AU - Jung Ki Min AU - Daeun Park AU - Hanwoong Woo AU - Sohee Kim AU - Juyeon Lee AU - Yeonsu Kim AU - Jeong-im Choi AU - Eunbi Lim AU - Sehyun Chae AU - Jieun Kim PY - 2026 JO - Frontiers in Immunology DO - 10.3389/fimmu.2026.1899666 UR - https://doi.org/10.3389/fimmu.2026.1899666 ER -
APA
Min, J. K., Park, D., Woo, H., Kim, S., Lee, J., Kim, Y., Choi, J., Lim, E., Chae, S., & Kim, J. (2026). Selpercatinib mitigates microglia-mediated neuroinflammation by inhibiting RET signaling and NLRP3 inflammasome activation. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1899666
Source records
- crossref · retrieved 2026-11-10T11:06:41.170Z